
“Our partnership enables patients in China to participate in clinical trials testing novel neurodegenerative disease therapeutics. In November 2021, following ERT and Bioclinica merger, the company renames as Clario. Bioclinica evaluates qualified applicants without regard to race, color, religion, gender. Joe Eazor will be the head of the new business.
Clario bioclinica trial#
Clario was founded in 1972 and is based in Philadelphia, Pennsylvania. Drug Safety Associate Salaries in Bijpur (India) provided anonymously by employees. In December 2020, ERT announced a merger with Bioclinica, a global clinical trial end-point solutions company. “XingImaging is proud to be working with Clario in providing PET imaging multi-center clinical trials,” says Gilles Tamagnan, CEO XingImaging, LLC. DESCRIPTION Clario offers a compelling combination of technology, services, and clinical expertise, helping customers to deliver successful clinical trial outcomes by ensuring high-quality data capture, reduced costs, and shortened study timelines. “Our continued partnership with XingImaging is advancing therapeutics in APAC.” “Broadening our scope of clinical trials to further support drug development in neuroscience presents a unique opportunity for both patients and clinical researchers,” says Joyce Suhy, PhD, SVP Medical Imaging at Clario. The new expanded offering leverages the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China, including amyloid, tau, and other targets. Review collected by and hosted on G2.com. It includes various components however each of them are pretty easy to use and understand. A dedicated team of neuroscientists and project managers have led multiple trials in China to date. The best part about Bioclinica CTMS, now Clario is the ease of operating the system. View the job description, responsibilities and qualifications for this position. It offers eCOA, electronic clinical outcome assessments that measure how patients feel or function during clinical trials, medical imaging, pulmonary function testing, and precision motion monitoring and actigraphy devices, patient safety monitoring. Apply for the Job in Medical Director at Princeton, NJ. PET imaging has supported novel studies for Alzheimer’s disease (AD) and other neurodegenerative diseases. Clario (also known as eResearchTechnology, formerly ERT) is a developer of clinical data collection solutions for use in clinical trials.

Integration of eTMF and CTMS eliminates redundancies, improves workflows, enhances transparency and enables greater study control.Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, have expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China.Ĭlario, formerly ERT and Bioclinica, and XingImaging joined forces in 2018 to support multi-center clinical trials requiring PET for eligibility and drug efficacy evaluation.

Keith Parent, Co-Founder and Partner at RegDocs365, Founder and CEO, Court Square GroupĮlectronic trial master file (eTMF) management has traditionally been conducted separately from the clinical trial management system (CTMS), which often needs to track documents within the eTMF.Jeremiah Rehm, Senior Product Manager, Bioclinica.

SharePoint-Enabled CTMS & eTMF for a Single Source of the Truth for Document, Content & Study Management 1-88 for US and Canada For additional information and to locate specific toll-free numbers, go to and click the Support link at the top of the screen, then click Bioclinica Support. ERT & Bioclinica have become Clario, and I am delighted to be part of the team that is shaping the future of clinical trials clinicaltrials healthcare. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and global scale into the broadest endpoint technology platform. Jeremiah Rehm, Senior Product Manager, Bioclinica Keith Parent, Co-Founder and Partner at RegDocs365, Founder and CEO, Court Square Group Electronic trial master file (eTMF) management has traditionally been conducted separately from the clinical trial management system (CTMS), which often needs to track documents within the eTMF.
